One cannot discriminate, however, from the data of our study whether there is absolute lack of an effect or whether apoB levels remain eventually elevated due to counter-acting effects of overproduction of apoB, which is known to occur in HD patients (Chan et al. 1989), and a probable apoB-lowering effect of systemic inflammation and malnutrition. The gene discussed is APOB; the disease is Huntington disease.